Amneal Pharmaceuticals, Inc. (AMRX) — Dilution Risk Analysis

Current Snapshot

Amneal Pharmaceuticals, Inc. (AMRX) has a DilutionWatch score of 14/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
319,353,919 Source
Public Float
178,410,306 Source
Float as % of Outstanding
55.9%

Dilution Risk Score

Score: 14/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: FORM 4 1, 4 9.

FormFiledAccession
Form 4 2026-08-10 0000898432-26-000655|0001745375|2026-08-10|A|12763469
4 2026-03-05 0001628280-26-015235
4 2026-03-05 0001628280-26-015238
4 2026-03-05 0001628280-26-015239
4 2026-03-05 0001628280-26-015241
4 2026-03-05 0001628280-26-015283
4 2026-03-05 0001628280-26-015285
4 2026-03-03 0001628280-26-013878
4 2026-03-03 0001628280-26-013882
4 2026-03-03 0001628280-26-013887

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 999 months Source
Three-year share count growth 4.02% Source

DilutionWatch Analysis

Risk Level
LOW (Score: 14/10) Source
Cash Runway
999 months Source
Share Count Growth (3-Year)
4.02% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.